LATUDA: payments to doctors
Payments that named LATUDA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.8M
- Providers
- 20,506
- Transactions
- 204,719
- Average per transaction
- $38
The per-transaction average — $38 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 20,506 providers the average total is $379, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | $7,549,991 | 97.1% |
| Sumitomo Dainippon Pharma Co., Ltd. | $123,702 | 1.6% |
| Sumitomo Pharma Co., Ltd. | $100,013 | 1.3% |
| Sumitomo Pharma America, Inc. | $3,842 | 0.0% |